We are a biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications.
We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications.